Cite
Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia
MLA
Koji Kato, et al. “Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with Chronic Myeloid Leukemia.” The Journal of Pediatrics, vol. 159, no. 4, Nov. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....476dde87955c5ba4e1df9ff6df679e22&authtype=sso&custid=ns315887.
APA
Koji Kato, Hidemitsu Kurosawa, Kazuko Hamamoto, Masahito Tsurusawa, Akihiro Watanabe, Hideki Muramatsu, Hiroyuki Shimada, Masaki Ito, Akihiko Tanizawa, Haruko Shima, Chikako Tono, Noriko Hotta, Mika Tokuyama, & Keizo Horibe. (2010). Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia. The Journal of Pediatrics, 159(4).
Chicago
Koji Kato, Hidemitsu Kurosawa, Kazuko Hamamoto, Masahito Tsurusawa, Akihiro Watanabe, Hideki Muramatsu, Hiroyuki Shimada, et al. 2010. “Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with Chronic Myeloid Leukemia.” The Journal of Pediatrics 159 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....476dde87955c5ba4e1df9ff6df679e22&authtype=sso&custid=ns315887.